Ready to play
Ready to play
Reports indicate that the American company Pfizer has received approval from US authorities to begin testing a vaccine against monkeypox. The study will involve 4,734 participants and is expected to continue until July 2026, aiming to assess the safety and effectiveness of the vaccine in preventing the disease.
Notice: This Is an AI-Generated Summary
Comments (0)